Quick Connect Send a message
Dr. Reddy’s API team participated in CPHI Japan 2026, held at Tokyo Big Sight, engaging with global pharmaceutical stakeholders across the ingredients and manufacturing value chain. CPHI Japan is widely recognised as a key platform connecting international suppliers with the highly regulated Japanese and Asia‑Pacific markets.
During the event, the team interacted with customers and partners to discuss complex APIs, advanced manufacturing processes, quality, and regulatory expectations, reflecting the evolving needs of global pharma supply chains. Japan’s strong focus on quality and compliance made the event particularly relevant for discussions around long‑term partnerships and sustainable sourcing. Participation at CPHI Japan 2026 reaffirmed Dr. Reddy’s commitment to delivering reliable, compliant, and scalable API solutions to customers worldwide.
No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.
+91 4049002253